On the “Take” as a Biomarker
Authors:
- 14 November 2019
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 381 (20) , 1962-1963
Abstract
Arguably the best biomarker in the world for vaccine efficacy is the “take.” The take, the reaction observed after an inoculation of smallpox vaccine, is typically a small pustular lesion that occurs approximately 1 week after inoculation and often leaves a poxlike scar at the vaccination site. This reaction allows health care personnel to know that a person is immune to variola and that the immunity is long-lasting. This simple observation, which was reported by Edward Jenner in the late 1700s and could be recognized by anyone anywhere in the world, contributed enormously to the eradication of the disease, with . . .Keywords
This publication has 11 references indexed in Scilit:
- Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against SmallpoxNew England Journal of Medicine, 2019
- Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragmentsPLOS ONE, 2018
- Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled TrialThe Journal of Infectious Diseases, 2013
- Prospective Surveillance for Cardiac Adverse Events in Healthy Adults Receiving Modified Vaccinia Ankara Vaccines: A Systematic ReviewPLOS ONE, 2013
- Analysis of Variola and Vaccinia Virus Neutralization Assays for Smallpox VaccinesClinical and Vaccine Immunology, 2012
- Effect of Vaccination with Modified Vaccinia Ankara (ACAM3000) on Subsequent Challenge with DryvaxThe Journal of Infectious Diseases, 2010
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate CancerJournal of Clinical Oncology, 2010
- Evaluation of smallpox vaccines using variola neutralizationJournal of General Virology, 2009
- Adverse Events Associated With Smallpox Vaccination in the United States, January-October 2003JAMA, 2005
- Smallpox as a Biological WeaponJAMA, 1999